Environmental presence and persistence of pharmaceuticals an overview

Fate of Pharmaceuticals in the Environment and in Water Treatment Systems

Volumn , Issue , 2007, Pages 3-52

  Glassmeyer, Susan T ^a   Kolpin, Dana W ^b   Furlong, Edward T ^c   Focazio, Michael J ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b U S GEOLOGICAL SURVEY   (United States)

^c DENVER FEDERAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85055507051     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420052336     Document Type: Chapter

References (152)

1. Daughton, C.G. and Ternes, T.A., Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environmental Health Perspectives 107, 907-938, 1999.
2. Kolpin, D.W., Furlong, E.T., Meyer, M.T., Thurman, E.M., Zaugg, S.D., Barber, L.B., and Buxton, H.T., Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance, Environmental Science & Technology 36 (6), 1202-1211, 2002.
3. Heberer, T., Schmidt-Baumler, K., and Stan, H.J., Occurrence and distribution of organic contaminants in the aquatic system in Berlin. Part 1: Drug residues and other polar contaminants in Berlin surface and groundwater, Acta Hydrochimica Et Hydrobiologica 26 (5), 272-278, 1998.
4. Ternes, T.A., Occurrence of drugs in German sewage treatment plants and rivers, Water Research 32 (11), 3245-3260, 1998.
5. Buxton, H.T. and Kolpin, D.W., Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams: U.S. Geological Survey Fact Sheet FS-027-02, p. 2, 2002.
6. Verstraeten, I.M., Fetterman, G.S., Meyer, M.T., Bullen, T., and Sebree, S.K., Use of tracers and isotopes to evaluate vulnerability of water in domestic wells to septic waste, Ground Water Monitoring and Remediation 25 (2), 107-117, 2005.
7. Rodriguez-Mozaz, S., de Alda, M. J.L., and Barcelo, D., Monitoring of estrogens, pesticides and bisphenol A in natural waters and drinking water treatment plants by solid-phase extraction-liquid chromatography-mass spectrometry, Journal of Chromatography A 1045 (1-2), 85-92, 2004.
8. Kreuzinger, N., Clara, M., Strenn, B., and Vogel, B., Investigation on the behaviour of selected pharmaceuticals in the groundwater after infiltration of treated wastewater, Water Science and Technology 50 (2), 221-228, 2004.
9. Heberer, T., Mechlinski, A., Fanck, B., Knappe, A., Massmann, G., Pekdeger, A., and Fritz, B., Field studies on the fate and transport of pharmaceutical residues in bank filtration, Ground Water Monitoring and Remediation 24 (2), 70-77, 2004.
10. Bruchet, A., Hochereau, C., Picard, C., Decottignies, V., Rodrigues, J.M., and Janex-Habibi, M.L., Analysis of drugs and personal care products in French source and drinking waters: The analytical challenge and examples of application, Water Science and Technology 52 (8), 53-61, 2005.
11. Scheytt, T., Mersmann, P., Leidig, M., Pekdeger, A., and Heberer, T., Transport of pharmaceutically active compounds in saturated laboratory columns, Ground Water 42 (5), 767-773, 2004.
12. Barnes, K.K., Christenson, S.C., Kolpin, D.W., Focazio, M., Furlong, E.T., Zaugg, S.D., Meyer, M.T., and Barber, L.B., Pharmaceuticals and other organic waste water contaminants within a leachate plume downgradient of a municipal landfill, Ground Water Monitoring and Remediation 24 (2), 119-126, 2004.
13. Bound, J.P. and Voulvoulis, N., Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom, Environmental Health Perspectives 113 (12), 1705-1711, 2005.
14. Slack, R.J., Gronow, J., and Vulvulis, N., Household hazardous waste in municipal landfills: Contaminants in leachate, Science of the Total Environment 337 (1-3), 119-137, 2005.
15. Slack, R.J., Zerva, P., Gronow, J.R., and Voulvoulis, N., Assessing quantities and disposal routes for household hazardous products in the United Kingdom, Environmental Science & Technology 39 (6), 1912-1919, 2005.
16. Aguera, A., Fernandez-Alba, A.R., Piedra, L., Mezcua, M., and Gomez, M.J., Evaluation of triclosan and biphenylol in marine sediments and urban wastewaters by pressurized liquid extraction and solid phase extraction followed by gas chromatography mass spectrometry and liquid chromatography mass spectrometry, Analytica Chimica Acta 480 (2), 193-205, 2003.
17. Morales-Munoz, S., Luque-Garcia, J.L., Ramos, M.J., Fernandez-Alba, A., and de Castro, M.D.L., Sequential superheated liquid extraction of pesticides, pharmaceutical and personal care products with different polarity from marine sediments followed by gas chromatography mass spectrometry detection, Analytica Chimica Acta 552 (1-2), 50-59, 2005.
18. Harrison, E.Z., Oakes, S.R., Hysell, M., and Hay, A., Organic chemicals in sewage sludges, Science of the Total Environment 367 (2-3), 481-497, 2006.
19. Kinney, C.A., Furlong, E.T., Zaugg, S.D., Burkhardt, M.R., Werner, S.L., Cahill, J.D., and Jorgensen, G.R., Survey of organic wastewater contaminants in biosolids destined for land application, Environmental Science & Technology 40 (23), 7207-7215, 2006.
20. Glassmeyer, S.T., Furlong, E.T., Kolpin, D.W., Cahill, J.D., Zaugg, S.D., Werner, S.L., Meyer, M.T., and Kryak, D.D., Transport of chemical and microbial compounds from known wastewater discharges: Potential for use as indicators of human fecal contamination, Environmental Science & Technology 39 (14), 5157-5169, 2005.
21. Ashton, D., Hilton, M., and Thomas, K.V., Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom, Science of the Total Environment 333 (1-3), 167-184, 2004.
22. Batt, A.L., Bruce, I.B., and Aga, D.S., Evaluating the vulnerability of surface waters to antibiotic contamination from varying wastewater treatment plant discharges, Environmental Pollution 142 (2), 295-302, 2006.
23. Gros, M., Petrovic, M., and Barcelo, D., Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters., Talanta 70, 678-690, 2006.
24. Masters, R.W., Verstraeten, I.M., and Heberer, T., Fate and transport of pharmaceuticals and endocrine disrupting compounds during ground water recharge, Ground Water Monitoring and Remediation 24 (2), 54-57, 2004.
25. Drewes, J.E., Heberer, T., Rauch, T., and Reddersen, K., Fate of pharmaceuticals during ground water recharge, Ground Water Monitoring and Remediation 23, 64-72, 2003.
26. Asano, T. and Cotruvo, J.A., Groundwater recharge with reclaimed municipal wastewater: Health and regulatory considerations, Water Research 38, 1941-1951, 2004.
27. Cordy, G.E., Duran, N.L., Bouwer, H., Rice, R.C., Furlong, E.T., Zaugg, S.D., Meyer, M.T., Barber, L.B., and Kolpin, D.W., Do pharmaceuticals, pathogens, and other organic waste water compounds persist when waste water is used for recharge? Ground Water Monitoring and Remediation 24 (2), 58-69, 2004.
28. Matamoros, V., Garcia, J., and Bayona, J.M., Behavior of selected pharmaceuticals in subsurface flow constructed wetlands: A pilot-scale study, Environmental Science & Technology 39 (14), 5449-5454, 2005.
29. Zuehlke, S., Duennbier, U., Heberer, T., and Fritz, B., Analysis of endocrine disrupting steroids: Investigation of their release into the environment and their behavior during bank filtration, Ground Water Monitoring and Remediation 24 (2), 78-85, 2004.
30. Snyder, S.A., Leising, J., Westerhoff, P., Yoon, Y., Mash, H., and Vanderford, B., Biological and physical attenuation of endocrine disruptors and pharmaceuticals: Implications for water reuse, Ground Water Monitoring and Remediation 24 (2), 108-118, 2004.
31. Kinney, C.A., Furlong, E.T., Werner, S.L., and Cahill, J.D., Presence and distribution of wastewater-derived pharmaceuticals in soil irrigated with reclaimed water, Environmental Toxicology and Chemistry 25 (2), 317-326, 2006.
32. Pedersen, J.A., Soliman, M., and Suffet, I.H., Human pharmaceuticals, hormones, and personal care product ingredients in runoff from agricultural fields irrigated with treated wastewater, Journal of Agricultural and Food Chemistry 53 (5), 1625-1632, 2005.
33. Buyuksonmez, F. and Sekeroglu, S., Presence of pharmaceuticals and personal care products (PPCPs) in biosolids and their degradation during composting, Journal of Residuals Science & Technology 2 (1), 31-40, 2005.
34. Overcash, M., Sims, R.C., Sims, J.L., and Nieman, J.K.C., Beneficial reuse and sustainability: The fate of organic compounds in land-applied waste, Journal of Environmental Quality 34 (1), 29-41, 2005.
35. Xia, K., Bhandari, A., Das, K., and Pillar, G., Occurrence and fate of pharmaceuticals and personal care products (PPCPs) in biosolids, Journal of Environmental Quality 34 (1), 91-104, 2005.
36. Zuccato, E., Castiglioni, S., and Fanelli, R., Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment, Journal of Hazardous Materials 122 (3), 205-209, 2005.
37. Gross, B., Montgomery-Brown, J., Naumann, A., and Reinhard, M., Occurrence and fate of pharmaceuticals and alkylphenol ethoxylate metabolites in an effluent-dominated river and wetland, Environmental Toxicology and Chemistry 23 (9), 2074-2083, 2004.
38. Lindqvist, N., Tuhkanen, T., and Kronberg, L., Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters, Water Research 39 (11), 2219-2228, 2005.
39. Verenitch, S.S., Lowe, C.J., and Mazumder, A., Determination of acidic drugs and caffeine in municipal wastewaters and receiving waters by gas chromatography-ion trap tandem mass spectrometry, Journal of Chromatography A 1116 (1-2), 193-203, 2006.
40. Brun, G.L., Bernier, M., Losier, R., Doe, K., Jackman, P., and Lee, H.B., Pharmaceutically active compounds in Atlantic Canadian sewage treatment plant effluents and receiving waters, and potential for environmental effects as measured by acute and chronic aquatic toxicity, Environmental Toxicology and Chemistry 25, 2163-2176, 2006.
41. Batt, A.L., Snow, D.D., and Aga, D.S., Occurrence of sulfonamide antimicrobials in private water wells in Washington County, Idaho, USA, Chemosphere 64 (11), 1963-1971, 2006.
42. Brown, K.D., Kulis, J., Thomson, B., Chapman, T.H., and Mawhinney, D.B., Occurrence of antibiotics in hospital, residential, and dairy, effluent, municipal wastewater, and the Rio Grande in New Mexico, Science of the Total Environment 366 (2-3), 772-783, 2006.
43. Cabello, F.C., Heavy use of prophylactic antibiotics in aquaculture: A growing problem for human and animal health and for the environment, Environmental Microbiology 8 (7), 1137-1144, 2006.
44. Dietze, J.E., Scribner, E.A., Meyer, M.T., and Kolpin, D.W., Occurrence of antibiotics in water from 13 fish hatcheries, 2001-2003, International Journal of Environmental Analytical Chemistry 85 (15), 1141-1152, 2005.
45. Lee, H.B., Peart, T.E., and Svoboda, M.L., Determination of endocrine-disrupting phenols, acidic pharmaceuticals, and personal-care products in sewage by solid-phase extraction and gas chromatography-mass spectrometry, Journal of Chromatography A 1094 (1-2), 122-129, 2005.
46. Quintana, J.B. and Reemtsma, T., Sensitive determination of acidic drugs and triclosan in surface and wastewater by ion-pair reverse-phase liquid chromatography/tandem mass spectrometry, Rapid Communications in Mass Spectrometry 18 (7), 765-774, 2004.
47. Quintana, J.B., Rodil, R., and Reemtsma, T., Suitability of hollow fibre liquid-phase microextraction for the determination of acidic pharmaceuticals in wastewater by liquid chromatography-electrospray tandem mass spectrometry without matrix effects, Journal of Chromatography A 1061 (1), 19-26, 2004.
48. Quintana, J.B., Weiss, S., and Reemtsma, T., Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor, Water Research 39 (12), 2654-2664, 2005.
49. Clara, M., Strenn, B., Gans, O., Martinez, E., Kreuzinger, N., and Kroiss, H., Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants, Water Research 39 (19), 4797-4807, 2005.
50. Bendz, D., Paxeus, N.A., Ginn, T.R., and Loge, F.J., Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden, Journal of Hazardous Materials 122 (3), 195-204, 2005.
51. Santos, J.L., Aparicio, I., Alonso, E., and Callejon, M., Simultaneous determination of pharmaceutically active compounds in wastewater samples by solid phase extraction and high-performance liquid chromatography with diode array and fluorescence detectors, Analytica Chimica Acta 550 (1-2), 116-122, 2005.
52. Miao, X.S., Yang, J.J., and Metcalfe, C.D., Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant, Environmental Science & Technology 39 (19), 7469-7475, 2005.
53. Roberts, P.H. and Thomas, K.V., The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment, Science of the Total Environment 356 (1-3), 143-153, 2006.
54. Stackelberg, P.E., Furlong, E.T., Meyer, M.T., Zaugg, S.D., Henderson, A.K., and Reissman, D.B., Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-watertreatment plant, Science of the Total Environment 329 (1-3), 99-113, 2004.
55. Westerhoff, P., Yoon, Y., Snyder, S., and Wert, E., Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes, Environmental Science & Technology 39 (17), 6649-6663, 2005.
56. Jones, O.A., Lester, J.N., and Voulvoulis, N., Pharmaceuticals: A threat to drinking water? Trends in Biotechnology 23 (4), 163-167, 2005.
57. Snyder, S.A., Westerhoff, P., Yoon, Y., and Sedlak, D.L., Pharmaceuticals, personal care products, and endocrine disruptors in water: Implications for the water industry, Environmental Engineering Science 20 (5), 449-469, 2003.
58. Hernando, M.D., Heath, E., Petrovic, M., and Barcelo, D., Trace-level determination of pharmaceutical residues by LC-MS/MS in natural and treated waters. A pilot-survey study, Analytical and Bioanalytical Chemistry 385 (6), 985-991, 2006.
59. Rule, K.L., Ebbett, V.R., and Vikesland, P.J., Formation of chloroform and chlorinated organics by free-chlorine-mediated oxidation of triclosan, Environmental Science & Technology 39 (9), 3176-3185, 2005.
60. Dodd, M.C. and Huang, C.H., Transformation of the antibacterial agent sulfamethoxazole in reactions with chlorine: Kinetics mechanisms, and pathways, Environmental Science & Technology 38 (21), 5607-5615, 2004.
61. Seitz, W., Jiang, J.Q., Weber, W.H., Lloyd, B.J., Maier, M., and Maier, D., Removal of iodinated X-ray contrast media during drinking water treatment, Environmental Chemistry 3 (1), 35-39, 2006.
62. Cunningham, V.L., Buzby, M., Hutchinson, T., Mastrocco, F., Parke, N., and Roden, N., Effects of human pharmaceuticals on aquatic life: Next steps, Environmental Science & Technology 40 (11), 3456-3462, 2006.
63. Sanderson, H., Johnson, D.J., Reitsma, T., Brain, R.A., Wilson, C.J., and Solomon, K.R., Ranking and prioritization of environmental risks of pharmaceuticals in surface waters, Regulatory Toxicology and Pharmacology 39 (2), 158-183, 2004.
64. Fent, K., Weston, A.A., and Caminada, D., Ecotoxicology of human pharmaceuticals, Aquatic Toxicology 76 (2), 122-159, 2006.
65. Richards, S.M., Wilson, C.J., Johnson, D.J., Castle, D.M., Lam, M., Mabury, S.A., Sibley, P.K., and Solomon, K.R., Effects of pharmaceutical mixtures in aquatic microcosms, Environmental Toxicology and Chemistry 23 (4), 1035-1042, 2004.
66. Mimeault, C., Woodhouse, A., Miao, X.S., Metcalfe, C.D., Moon, T.W., and Trudeau, V.L., The human lipid regulator, gemfibrozil bioconcentrates and reduces testosterone in the goldfish, Carassius auratus, Aquatic Toxicology 73 (1), 44-54, 2005.
67. Swan, G., Naidoo, V., Cuthbert, R., Green, R.E., Pain, D.J., Swarup, D., Prakash, V., Taggart, M., Bekker, L., Das, D., Diekmann, J., Diekmann, M., Killian, E., Meharg, A., Patra, R.C., Saini, M., and Wolter, K., Removing the threat of diclofenac to critically endangered Asian vultures, Plos Biology 4 (3), 395-402, 2006.
68. Meteyer, C.U., Rideout, B.A., Gilbert, M., Shivaprasad, H.L., and Oaks, J.L., Pathology and proposed pathophysiology of diclofenac poisoning in free-living and experimentally exposed oriental white-backed vultures (Gyps bengalensis), Journal of Wildlife Diseases 41 (4), 707-716, 2005.
69. Pomati, F., Castiglioni, S., Zuccato, E., Fanelli, R., Vigetti, D., Rossetti, C., and Calamari, D., Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells, Environmental Science & Technology 40 (7), 2442-2447, 2006.
70. Jones, A.H., Voulvoulis, N., and Lester, J.N., Potential ecological and human health risks associated with the presence of pharmaceutically active compounds in the aquatic environment, Critical Reviews in Toxicology 34 (4), 335-350, 2004.
71. Halling-Sorensen, B., Nielsen, S.N., Lanzky, P.F., Ingerslev, F., Lutzhoft, H.C.H., and Jorgensen, S.E., Occurrence, fate and effects of pharmaceutical substances in the environment— A review, Chemosphere 36 (2), 357-394, 1998.
72. Heberer, T., Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: A review of recent research data, Toxicology Letters 131 (1-2), 5-17, 2002.
73. Diaz-Cruz, S. and Barcelo, D., Occurrence and analysis of selected pharmaceuticals and metabolites as contaminants present in waste waters, sludge and sediments, in Emerging Organic Pollutants in Waste Waters and Sludge, 15, 227-260, Part I, 2004.
74. Kosjek, T., Heath, E., and Krbavcic, A., Determination of non-steroidal anti-inflammatory drug (NSAIDs) residues in water samples, Environment International 31 (5), 679-685, 2005.
75. Lin, W.C., Chen, H.C., and Ding, W.H., Determination of pharmaceutical residues in waters by solid-phase extraction and large-volume on-line derivatization with gas chromatography-mass spectrometry, Journal of Chromatography A 1065 (2), 279-285, 2005.
76. Mitani, K. and Kataoka, H., Determination of fluoroquinolones in environmental waters by in-tube solid-phase microextraction coupled with liquid chromatographytandem mass spectrometry, Analytica Chimica Acta 562 (1), 16-22, 2006.
77. Moldovan, Z., Occurrences of pharmaceutical and personal care products as micropollutants in rivers from Romania, Chemosphere 64, 1808-1817, 2006.
78. Yasojima, M., Nakada, N., Komori, K., Suzuki, Y., and Tanaka, H., Occurrence of levofloxacin, clarithromycin and azithromycin in wastewater treatment plant in Japan, Water Science and Technology 53 (11), 227-233, 2006.
79. Richardson, B.J., Larn, P.K.S., and Martin, M., Emerging chemicals of concern: Pharmaceuticals and personal care products (PPCPs) in Asia, with particular reference to Southern China, Marine Pollution Bulletin 50 (9), 913-920, 2005.
80. USEPA, Onsite Wastewater Treatment Systems Manual, USEPA EPA-625-R-00-008, 2002.
81. U.S. Census Bureau, Historical Census of Housing Tables: Sewage Disposal, http://www.census.gov/hhes/www/housing/census/historic/sewage.html, 1990.
82. Kümmerer, K., Pharmaceuticals in the environment-scope of the book and introduction, in Pharmaceuticals in the Environment—Sources, Fate, Effects, and Risk Second Edition, Kummerer, K. Springer, Berlin Heidelberg, 2004
83. Managaki, S., Takada, H., Kim, D.-M., Horiguchi, T., and Shiraishi, H., Three-dimensional distributions of sewage markers in Tokyo Bay water-fluorescent whitening agents, Marine Pollution Bulletin 52, 281-292, 2006.
84. Eganhouse, R.P. and Sherblom, P.M., Anthropogenic organic contaminants in the effluent of a combined sewer overflow: Impact on Boston Harbor, Marine Environmental Research 51, 51-74, 2001.
85. Diez, S., Jover, E., Albaiges, J., and Bayona, J.M., Occurrence and degradation of butyltins and wastewater marker compounds in sediments from Barcelona Harbor, Spain, Environment International 32, 858-865, 2006.
86. Ternes, T.A., Joss, A., and Siegrist, H., Scrutinizing pharmaceuticals and personal care products in wastewater treatment, Environmental Science & Technology 38 (20), 392A-399A, 2004.
87. Göbel, A., Thomsen, A., McArdell, C.S., Joss, A., and Giger, W., Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment, Environmental Science & Technology 39 (11), 3981-3989, 2005.
88. USEPA, Biosolids generation, use, and disposal in the United States, USEPA EPA-530-R-99-009, 1999.
89. USEPA, http:/www.epa.gov/owm/mtb/biosolids/genqa.htm, 2003.
90. Gurr, C.J. and Reinhard, M., Harnessing natural attenuation of pharmaceuticals and hormones in rivers, Environmental Science & Technology 40 (9), 2872-2876, 2006.
91. Perez-Estrada, L.A., Malato, S., Gernjak, W., Aguera, A., Thurman, E.M., Ferrer, I., and Fernandez-Alba, A.R., Photo-fenton degradation of diclofenac: Identification of main intermediates and degradation pathway, Environmental Science & Technology 39 (21), 8300-8306, 2005.
92. Lin, A.Y.C. and Reinhard, M., Photodegradation of common environmental pharmaceuticals and estrogens in river water, Environmental Toxicology and Chemistry 24 (6), 1303-1309, 2005.
93. Andreozzi, R., Raffaele, M., and Nicklas, P., Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment, Chemosphere 50 (10), 1319-1330, 2003.
94. Kwon, J.W. and Armbrust, K.L., Degradation of citalopram by simulated sunlight, Environmental Toxicology and Chemistry 24 (7), 1618-1623, 2005.
95. Lam, M.W. and Mabury, S.A., Photodegradation of the pharmaceuticals atorvastatin, carbamazepine, levofloxacin, and sulfamethoxazole in natural waters, Aquatic Sciences 67 (2), 177-188, 2005.
96. Packer, J.L., Werner, J.J., Latch, D.E., McNeill, K., and Arnold, W.A., Photochemical fate of pharmaceuticals in the environment: Naproxen, diclofenac, clofibric acid, and ibuprofen, Aquatic Sciences 65 (4), 342-351, 2003.
97. Perez, S., Eichhorn, P., and Aga, D.S., Evaluating the biodegradability of sulfamethazine, sulfamethoxazole, sulfathiazole, and trimethoprim at different stages of sewage treatment, Environmental Toxicology and Chemistry 24 (6), 1361-1367, 2005.
98. Kim, S., Eichhorn, P., Jensen, J.N., Weber, A.S., and Aga, D.S., Removal of antibiotics in wastewater: Effect of hydraulic and solid retention times on the fate of tetracycline in the activated sludge process, Environmental Science & Technology 39 (15), 5816-5823, 2005.
99. Carucci, A., Cappai, G., and Piredda, M., Biodegradability and toxicity of pharmaceuticals in biological wastewater treatment plants, Journal of Environmental Science and Health Part A—Toxic/Hazardous Substances & Environmental Engineering 41 (9), 1831-1842, 2006.
100. Lindberg, R.H., Olofsson, U., Rendahl, P., Johansson, M.I., Tysklind, M., and Andersson, B.A.V., Behavior of fluoroquinolones and trimethoprim during mechanical, chemical, and active sludge treatment of sewage water and digestion of sludge, Environmental Science & Technology 40 (3), 1042-1048, 2006.
101. Boxall, A.B.A., Sinclair, C.J., Fenner, K., Kolpin, D., and Maud, S.J., When synthetic chemicals degrade in the environment, Environmental Science & Technology 38 (19), 368A-375A, 2004.
102. Kolpin, D.W., Skopec, M., Meyer, M.T., Furlong, E.T., and Zaugg, S.D., Urban contribution of pharmaceuticals and other organic wastewater contaminants to streams during differing flow conditions, Science of the Total Environment 328 (1-3), 119-130, 2004.
103. Bound, J.P. and Voulvoulis, N., Predicted and measured concentrations for selected pharmaceuticals in U.K. rivers: Implications for risk assessment, Water Research 40, 2885-2892, 2006.
104. Comoretto, L. and Chiron, S., Comparing pharmaceutical and pesticide loads into a small Mediterranean river, Science of the Total Environment 349 (1-3), 201-210, 2005.
105. Ternes, T.A., Meisenheimer, M., McDowell, D., Sacher, F., Brauch, H.J., Gulde, B.H., Preuss, G., Wilme, U., and Seibert, N.Z., Removal of pharmaceuticals during drinking water treatment, Environmental Science & Technology 36 (17), 3855-3863, 2002.
106. Loraine, G.A. and Pettigrove, M.E., Seasonal variations in concentrations of pharmaceuticals and personal care products in drinking water and reclaimed wastewater in Southern California, Environmental Science & Technology 40 (3), 687-695, 2006.
107. Glassmeyer, S.T. and Shoemaker, J.A., Effects of chlorination on the persistence of pharmaceuticals in the environment, Bulletin of Environmental Contamination and Toxicology 74 (1), 24-31, 2005.
108. Bedner, M. and Maccrehan, W.A., Transformation of acetaminophen by chlorination produces the toxicants 1,4-benzoquinone and N-acetyl-p-benzoquinone imine, Environmental Science & Technology 40 (2), 516-522, 2006.
109. Pinkston, K.E. and Sedlak, D.L., Transformation of aromatic ether-and amine-containing pharmaceuticals during chlorine disinfection, Environmental Science & Technology 38 (14), 4019-4025, 2004.
110. Naumann, K., Influence of chlorine substituents on biological activity of chemicals: A review (Reprinted from J Prakt Chem, Vol. 341, pp. 417-435, 1999), Pest Management Science 56 (1), 3-21, 2000.
111. Petty, J.D., Huckins, J.N., Alvarez, D.A., Brumbaugh, W.G., Cranor, W.L., Gale, R.W., Rastall, A.C., Jones-Lepp, T.L., Leiker, T.J., Rostad, C.E., and Furlong, E.T., A holistic passive integrative sampling approach for assessing the presence and potential impacts of waterborne environmental contaminants, Chemosphere 54 (6), 695-705, 2004.
112. Alvarez, D.A., Stackelberg, P.E., Petty, J.D., Huckins, J.N., Furlong, E.T., Zaugg, S.D., and Meyer, M.T., Comparison of a novel passive sampler to standard water-column sampling for organic contaminants associated with wastewater effluents entering a New Jersey stream, Chemosphere 61 (5), 610-622, 2005.
113. Jones-Lepp, T.L., Alvarez, D.A., Petty, J.D., and Huckins, J.N., Polar organic chemical integrative sampling and liquid chromatography-electrospray/ion-trap mass spectrometry for assessing selected prescription and illicit drugs in treated sewage effluents, Archives of Environmental Contamination and Toxicology 47 (4), 427-439, 2004.
114. Gourlay, C., Miege, C., Noir, A., Ravelet, C., Garric, J., and Mouchel, J.M., How accurately do semi-permeable membrane devices measure the bioavailability of polycyclic aromatic hydrocarbons to Daphnia magna? Chemosphere 61 (11), 1734-1739, 2005.
115. Voutsas, E., Magoulas, K., and Tassios, D., Prediction of the bioaccumulation of persistent organic pollutants in aquatic food webs, Chemosphere 48 (7), 645-651, 2002.
116. Haggard, B.E., Galloway, J.M., Green, W.R., and Meyer, M.T., Pharmaceuticals and other organic chemicals in selected north-central and northwestern Arkansas streams, Journal of Environmental Quality 35 (4), 1078-1087, 2006.
117. Brossa, L., Marce, R.A., Borrull, F., and Pocurull, E., Occurrence of twenty-six endocrine-disrupting compounds in environmental water samples from Catalonia, Spain, Environmental Toxicology and Chemistry 24 (2), 261-267, 2005.
118. Lishman, L., Smyth, S.A., Sarafin, K., Kleywegt, S., Toito, J., Peart, T., Lee, B., Servos, M., Beland, M., and Seto, P., Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada, Science of the Total Environment 367 (2-3), 544-558, 2006.
119. Zhang, S., Zhang, Q., Darisaw, S., Ehie, O., and Wang, G., Simultaneous quantification of polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and pharmaceuticals and personal care products (PPCPs) in Mississippi River water, in New Orleans, Louisiana, Chemosphere, 66, 1057-1069, 2007.
120. Gomez, M.J., Petrovic, M., Fernandez-Alba, A.R., and Barcelo, D., Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography-tandem mass spectrometry analysis in hospital effluent wastewaters, Journal of Chromatography A 1114 (2), 224-233, 2006.
121. Wiegel, S., Aulinger, A., Brockmeyer, R., Harms, H., Loffler, J., Reincke, H., Schmidt, R., Stachel, B., von Tumpling, W., and Wanke, A., Pharmaceuticals in the river Elbe and its tributaries, Chemosphere 57 (2), 107-126, 2004.
122. Castiglioni, S., Fanelli, R., Calamari, D., Bagnati, R., and Zuccato, E., Methodological approaches for studying pharmaceuticals in the environment by comparing predicted and measured concentrations in River Po, Italy, Regulatory Toxicology and Pharmacology 39 (1), 25-32, 2004.
123. Paxeus, N., Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment, Water Science and Technology 50 (5), 253-260, 2004.
124. Gobel, A., McArdell, C.S., Suter, M.J.F., and Giger, W., Trace determination of macrolide and sulfonamide antimicrobials, a human sulfonamide metabolite, and trimethoprim in wastewater using liquid chromatography coupled to electrospray tandem mass spectrometry, Analytical Chemistry 76 (16), 4756-4764, 2004.
125. Vieno, N.M., Tuhkanen, T., and Kronberg, L., Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water, Environmental Science & Technology 39 (21), 8220-8226, 2005.
126. Wolf, L., Held, I., Eiswirth, M., and Hotzl, H., Impact of leaky sewers on groundwater quality, Acta Hydrochimica Et Hydrobiologica 32 (4-5), 361-373, 2004.
127. Thomas, P.M. and Foster, G.D., Tracking acidic pharmaceuticals, caffeine, and triclosan through the wastewater treatment process, Environmental Toxicology and Chemistry 24 (1), 25-30, 2005.
128. Batt, A.L. and Aga, D.S., Simultaneous analysis of multiple classes of antibiotics by ion trap LC/MS/MS for assessing surface water and groundwater contamination, Analytical Chemistry 77 (9), 2940-2947, 2005.
129. Thomas, P.M. and Foster, G.D., Determination of nonsteroidal anti-inflammatory drugs, caffeine, and triclosan in wastewater by gas chromatography-mass spectrometry, Journal of Environmental Science and Health Part A—Toxic/Hazardous Substances & Environmental Engineering 39 (8), 1969-1978, 2004.
130. Zuehlke, S., Duennbier, U., and Heberer, T., Determination of polar drug residues in sewage and surface water applying liquid chromatography-tandem mass spectrometry, Analytical Chemistry 76 (22), 6548-6554, 2004.
131. Lissemore, L., Hao, C.Y., Yang, P., Sibley, P.K., Mabury, S., and Solomon, K.R., An exposure assessment for selected pharmaceuticals within a watershed in southern Ontario, Chemosphere 64 (5), 717-729, 2006.
132. Hao, C.Y., Lissemore, L., Nguyen, B., Kleywegt, S., Yang, P., and Solomon, K., Determination of pharmaceuticals in environmental waters by liquid chromatography/electrospray ionization/tandem mass spectrometry, Analytical and Bioanalytical Chemistry 384 (2), 505-513, 2006.
133. Yang, S. and Carlson, K., Routine monitoring of antibiotics in water and wastewater with a radioimmunoassay technique, Water Research 38 (14-15), 3155-3166, 2004.
134. Lindberg, R.H., Wennberg, P., Johansson, M.I., Tysklind, M., and Andersson, B.A.V., Screening of human antibiotic substances and determination of weekly mass flows in five sewage treatment plants in Sweden, Environmental Science & Technology 39 (10), 3421-3429, 2005.
135. Karthikeyan, K.G. and Meyer, M.T., Occurrence of antibiotics in wastewater treatment facilities in Wisconsin, USA, Science of the Total Environment 361 (1-3), 196-207, 2006.
136. Lindberg, R., Jarnheimer, P.A., Olsen, B., Johansson, M., and Tysklind, M., Determination of antibiotic substances in hospital sewage water using solid phase extraction and liquid chromatography/mass spectrometry and group analogue internal standards, Chemosphere 57 (10), 1479-1488, 2004.
137. Renew, J.E. and Huang, C.H., Simultaneous determination of fluoroquinolone, sulfonamide, and trimethoprim antibiotics in wastewater using tandem solid phase extraction and liquid chromatography-electrospray mass spectrometry, Journal of Chromatography A 1042 (1-2), 113-121, 2004.
138. Yang, S. and Carlson, K.H., Solid-phase extraction-high-performance liquid chromatography-ion trap mass spectrometry for analysis of trace concentrations of macrolide antibiotics in natural and waste water matrices, Journal of Chromatography A 1038 (1-2), 141-155, 2004.
139. Yang, S.W., Cha, J.M., and Carlson, K., Trace analysis and occurrence of anhydroerythromycin and tylosin in influent and effluent wastewater by liquid chromatography combined with electrospray tandem mass spectrometry, Analytical and Bioanalytical Chemistry 385 (3), 623-636, 2006.
140. Carballa, M., Omil, F., Lema, J.M., Llompart, M., Garcia-Jares, C., Rodriguez, I., Gomez, M., and Ternes, T., Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant, Water Research 38 (12), 2918-2926, 2004.
141. Vasskog, T., Berger, U., Samuelsen, P.J., Kallenborn, R., and Jensen, E., Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromso, Norway, Journal of Chromatography A 1115 (1-2), 187-195, 2006.
142. Verplanck, P.L., Taylor, H.E., Nordstrom, D.K., and Barber, L.B., Aqueous stability of gadolinium in surface waters receiving sewage treatment plant effluent, Boulder Creek, Colorado, Environmental Science & Technology 39 (18), 6923-6929, 2005.
143. Sandstrom, M.W., Kolpin, D.W., Thurman, E.M., and Zaugg, S.D., Widespread detection of N, N-diethyl-m-toluamide in US streams: Comparison with concentrations of pesticides, personal care products, and other organic wastewater compounds, Environmental Toxicology and Chemistry 24 (5), 1029-1034, 2005.
144. Nakata, H., Kannan, K., Jones, P.D., and Giesy, J.P., Determination of fluoroquinolone antibiotics in wastewater effluents by liquid chromatography-mass spectrometry and fluorescence detection, Chemosphere 58 (6), 759-766, 2005.
145. Fono, L.J. and Sedlak, D.L., Use of the chiral pharmaceutical propranolol to identify sewage discharges into surface waters, Environmental Science & Technology 39 (23), 9244-9252, 2005.
146. Perret, D., Gentili, A., Marchese, S., Greco, A., and Curini, R., Sulphonamide residues in Italian surface and drinking waters: A small scale reconnaissance, Chromatographia 63 (5-6), 225-232, 2006.
147. Waltman, E.L., Venables, B.J., and Waller, W.Z., Triclosan in a North Texas wastewater treatment plant and the influent and effluent of an experimental constructed wetland, Environmental Toxicology and Chemistry 25 (2), 367-372, 2006.
148. Canosa, P., Rodriguez, I., Rubi, E., and Cela, R., Optimization of solid-phase microextraction conditions for the determination of triclosan and possible related compounds in water samples, Journal of Chromatography A 1072 (1), 107-115, 2005.
149. Hua, W.Y., Bennett, E.R., and Letcher, R.J., Triclosan in waste and surface waters from the upper Detroit River by liquid chromatography-electrospray-tandem quadrupole mass spectrometry, Environment International 31 (5), 621-630, 2005.
150. Gobel, A., Thomsen, A., McArdell, C.S., Alder, A.C., Giger, W., Theiss, N., Loffler, D., and Ternes, T.A., Extraction and determination of sulfonamides, macrolides, and trimethoprim in sewage sludge, Journal of Chromatography A 1085 (2), 179-189, 2005.
151. Ternes, T.A., Herrmann, N., Bonerz, M., Knacker, T., Siegrist, H., and Joss, A., A rapid method to measure the solid-water distribution coefficient (K-d) for pharmaceuticals and musk fragrances in sewage sludge, Water Research 38 (19), 4075-4084, 2004.
152. Barber, L.B., Leenheer, J.A., Pereira, W.E., Noyes, T.I., Brown, G.K., Tabor, C.F., and Writer, J.H., Organic Contamination of the Mississippi River from Municipal and Industrial Wastewater, in Contaminants in the Mississippi River, US Geological Survey Circular 1133, Meade, R.H., U.S. Geological Survey, Reston, VA, 1995, http://pubs.usgs.gov/circ/circ1133/.